JAK3 and ischemic stroke: To further confirm that JAK3 inhibition is not neuroprotective in our model of ischemic stroke, we performed qRT-PCR to measure potential changes in ILs that use the common gamma chain associated with JAK3 and found no significant difference in the ipsilateral cortex between vehicle- and 10 mg/kg decernotinib-treated groups.